The US Food and Drug Administration (FDA) has issued final guidance on the electronic submission of documents related to the Risk Evaluation and Mitigation Strategies (REMS) using the Structured ...
Mark Gross offers a case study in using structured product labeling (SPL) to reduce time to market. For healthcare providers and their patients, time to approval and to market is everything, and every ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results